Safety of combining radiotherapy and antibody drug conjugates in advanced urothelial and other cancers. Impaired renal function and cisplatin-based regimens as risk factors for neoadjuvant ...

First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors for patients with BRAFV600E-mutated metastatic non-small cell lung cancer: The FRONT-BRAF study. Pooled ...

Please provide your email address to receive an email when new articles are posted on . Amivantamab-vmjw plus lazertinib significantly improved OS for certain patients with advanced NSCLC compared ...